Kövess feedeket: blogokat, híreket, RSS-t és még sok mást. Egyszerűbb módja annak, hogy olvasd és átlásd a neked fontos tartalmakat.
Feeder beszerzéseA Feeder felhasználói által leggyakrabban követett Gyógyszeripar RSS-hírcsatornák, köztük Agendas and minutes, New medicines: human és Regulatory and procedural guidelines (human and veterinary). Másold ki egy hírcsatorna URL-jét, vagy kövesd őket ingyen a Feederben.
Egészség RSS-feedek Onkológia RSS-feedek Klinikai vizsgálatok RSS-feedek Orvosi kutatás RSS-feedek Mentális egészség RSS-feedek Pszichológia RSS-feedek Közegészségügy RSS-feedek
Szerkesztés javaslataStay informed when new items, such as guidance documents, Summary Basis of Decisions for Drug Products, updates to the Registers of Innovative Drugs, policies and forms, are added to the Drug Products section of the website.
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]: Latest results from PubMed
Nature Chemical Biology is an interdisciplinary journal that publishes the most innovative and important research advances at the interface of chemistry and biology. The journal publishes research from chemists who are applying the principles, language and tools of chemistry to biological systems and from biologists who are interested in understanding biological processes at the molecular level. The scope of the journal covers all areas of contemporary research at the interface of chemistry and biology.
European Commission procedures on the change of status of human medicinal products
Keyword search result for Blog Series: In the Pipeline -- New results matching your keyword search query (updated daily).
New contents from the website www.hma.eu. Category: Recently Published Human Medicines
Our Guidance explains the laws and regulations governing the development, manufacturing, marketing, and supply of therapeutic goods in Australia.
Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena – from disease mechanisms, novel therapeutic approaches and chemistry to clinical trials and regulatory affairs. All reviews are carefully commissioned, written by leaders in the field and subject to rigorous peer-review so that readers receive independent, high-quality and authoritative articles in each issue. Reviews are complemented by news stories that investigate the key issues in drug discovery, timely summaries of significant published papers, market analysis, and updates on the latest advances in fast-moving areas such as new technologies, drug approvals and patent law. Information is presented at several levels that can be tailored to users’ individual needs. Non-specialists will benefit from the glossary and highlighted references, and experts will appreciate the insight provided by top names in their field. Nature Revi
Business Wire - The global leader in news distribution
Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions.
in-depth news, features and insights for the pharmaceutical and healthcare sectors
Health: Clinical Trials News Distributed by Business Wire